Hannah Le

Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population

Alpesh Amin, Allison Keshishian, Jeffrey Trocio et al. · Current Medical Research and Opinion · 2017 · 70 citations · Full text

Real-world Treatment Patterns and Clinical Outcomes Across Lines of Therapy in Patients With Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer

Dung T. Le, Patrick A. Ott, Beata Korytowsky et al. · Clinical Colorectal Cancer · 2019 · 44 citations · Full text

A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population

Alpesh Amin, Allison Keshishian, Jeffrey Trocio et al. · Journal of Managed Care & Specialty Pharmacy · 2018 · 29 citations · Full text

Oncologist and Patient Preferences for Novel Agents in First-Line Treatment for Chronic Lymphocytic Leukemia: Commonalities and Disconnects

Hannah Le, Kellie Ryan, Svea K. Wahlstrom et al. · Patient Preference and Adherence · 2021 · 27 citations · Full text

Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population

Saurabh Nagar, Shaum Kabadi, Hannah Le et al. · Cancer Medicine · 2021 · 27 citations · Full text